Actively Recruiting
Observational Registry Study on Mycobacterium Tuberculosis and Non-Tuberculous Mycobacteria Infections in Austria
Led by Ludwig Boltzmann Institute for Lung Health · Updated on 2024-07-26
1000
Participants Needed
3
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
This research aims to collect detailed data on patients diagnosed with tuberculosis TB or non-tuberculous mycobacteria NTM infections in Austria. The study is observational and does not involve additional treatments, focusing instead on understanding risk factors for death related to these infections over time. It documents the natural course of therapy as patients receive their regular medical care. Participants in this study are those already undergoing treatment for TB or NTM infections as part of their routine care. The study will gather clinical and epidemiological information throughout the treatment period without altering the therapy being received. No experimental interventions are involved. During participation, individuals will have their health and treatment progress monitored through data collection over a long period, up to 30 years. Researchers will evaluate mortality rates and identify risk factors for death related to mycobacterial infections. This long-term observation helps improve understanding of these diseases and their outcomes without requiring additional procedures or treatments from participants.
CONDITIONS
Brief Title
Mycobacteria Registry Study: Prospective Observational Study in Austria
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here